MedPath

Injection Oxytocin vs Injection Carbetocin in reduction of postpartum blood loss in caesarean sectio

Phase 2
Not yet recruiting
Conditions
Health Condition 1: O721- Other immediate postpartum hemorrhage
Registration Number
CTRI/2023/06/054091
Lead Sponsor
KLE Prabhakar Kore hospital and medical research centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Multiple pregnancy

2.Previous LSCS

3.Fibroids or Previous h/o Myomectomy

4.GDM

5.Previous history of PPH

6.Fetal macrosomia

7.Polyhydramnios

8.Hypertension and its disorders in pregnancy

9.Informed consent

Exclusion Criteria

1.Patients not willing to take part in the study

2.H/O Hypersensitivity to carbetocin

3.k/c/o epilepsy

4.Placenta Accreta spectrum

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out effectiveness of inj oxytocin vs inj carbetocin in reducing post partum blood loss in caesarean deliveriesTimepoint: 28 weeks POG
Secondary Outcome Measures
NameTimeMethod
To evaluate the EFFICACY OF CARBETOCIN VS OXYTOCIN on Additional use of uterotonic drugs <br/ ><br>Timepoint: 28 weeks- 42 weeks
© Copyright 2025. All Rights Reserved by MedPath